The litigation centers on a series of disclosures between February 2025 and May 2026, during which Cogent’s stock price suffered repeated double-digit declines. The complaint alleges that the company engaged in securities fraud or unlawful business practices, specifically regarding the accuracy of its wavelength backlog and growth projections. The firm points to a pattern of missed expectations, ranging from the removal of 1,500 legacy orders from the backlog in early 2025 to the sudden 98% reduction in quarterly dividends in November 2025.

Market confidence further eroded as management struggled to convert its reported backlog into actual revenue. By May 2026, CEO David Schaeffer acknowledged that customers were delaying the acceptance of wavelength installations due to external constraints. Following this admission, Cogent shares fell an additional 29%. Investors who acquired securities during the defined class period are now being encouraged to contact Danielle Peyton at Pomerantz LLP to participate in the ongoing legal proceedings.